Instruction for use: Epoetin omega

Trade name of the drug – Epomax

The Latin name of the substance Epoetin omega

Epoetinum omega (genus. Epoetini omega)

Chemical name

Omega- (1-165) -Erythropoietin (genetically engineered); A glycoprotein consisting of 165 amino acids

Pharmacological group:

Stimulators of hematopoiesis

The nosological classification (ICD-10)

D63.8 Anemia in other chronic diseases classified elsewhere: Anemia in chronic diseases; Anemia in immunological disorders; Anemia in peptic ulcer; Anemia in kidney diseases; Anemia with HIV treatment; Anemia in the background of chronic renal failure; Anemia in patients with myeloma; Symptomatic anemia; Symptomatic anemia of renal genesis; Anemia in HIV-infected patients; Renal anemia

Pharmacology

Mode action - Hematopoietic, erythropoietic.

Helps normalize the number of elements of red blood and the content of hemoglobin in them.

Application of the substance Epoetin omega

Anemia in the background of chronic renal failure.

Restrictions

Hypersensitivity, arterial hypertension, pregnancy (I trimester), breast-feeding (at the time of treatment stop), children's age.

Side effects of the substance Epoetin omega

Hyper- or hypotension, tachycardia, stenocardia, thrombosis, hyperkalemia, influenza-like symptoms, swelling, fatigue, calf muscle cramps, bronchitis, diarrhea, pruritis, anaphylactic shock.

Overdose

Symptoms: increased hematocrit, hemoglobin level, blood viscosity, hypertension, thrombosis.

Treatment: antihypertensive and / or anticoagulant therapy (against the background of the reversal of erythropoietin).

Routes of administration

SC or IV.

Precautions for the substance Epoetin omega

With caution appoint with CHD, convulsions and amnesia, in the II and III trimesters of pregnancy (only on strict indications and in the lowest doses). At least 1-2 times a week, it is necessary to monitor hemoglobin and hematocrit, potassium, creatinine and other serum levels. When treating patients with thrombosis, blood coagulability is tested once a month. Before treatment, it is necessary to exclude factors that may reduce the effect: insufficiency of vitamin B12 and folic acid, intoxication with aluminum, infections, corticosteroid therapy or immunosuppressants.